Medical Billing · Nationwide
Ophthalmology & Vitreoretinal Surgery Medical Billing Services
Anti-VEGF intravitreal injections, buy-and-bill drug reimbursement, bilateral surgery modifiers (-50 vs -LT/-RT), pars plana vitrectomy, and OCT diagnostic compliance.
Aethera Healthcare Solutions provides full-service medical billing and revenue cycle management to retina specialists, vitreoretinal surgeons, and ophthalmic surgery centers across the United States. We handle coding, claims, payment posting, denial management, and A/R follow-up end to end — so your team can stay focused on patient care while your revenue cycle runs cleanly.
Typical ophthalmology & vitreoretinal surgery CPT range we work: 67028, 67108, 67113, 67210, 67228, 92134, 92235, 92240, J0178, J2778, Q5128.
Why ophthalmology & vitreoretinal surgery billing leaks revenue
Intravitreal injection bilateral modifier denials: Payers rejecting CPT 67028 when billed with -50 instead of distinct -LT and -RT claim lines with 50% multiple procedure reductions
Buy-and-Bill anti-VEGF drug margin clawbacks: Expensive J-codes (J0178 Eylea, J2778 Lucentis, Q5128 Vabysmo) denied or underpaid due to missing NDC 11-digit formatting or mismatched units
Modifier JW / JZ drug wastage audit penalties: Audits and claim suspensions for failing to document single-dose vial (SDV) discarded milligrams on secondary claim lines
Diagnostic OCT (92134) frequency edits: Payers denying optical coherence tomography as exceeding medical LCD frequency thresholds during active anti-VEGF treatment cycles
How Aethera fixes it
Specialty-trained coders (CPC/CCS) code to the documentation
First-pass claim scrubbing against payer and NCCI edits
Proactive denial prevention and 72-hour denial work
Relentless A/R follow-up to drive days-in-A/R down
Eligibility and prior-auth verification before service
Transparent, real-time reporting in the provider portal
Free tools for your billing team
Use these any time — no login required.
Ophthalmology & Vitreoretinal Surgery billing FAQ
How should bilateral intravitreal injections (CPT 67028) be reported?
Billing rules vary by payer: Medicare Part B typically accepts CPT 67028 with Modifier 50 on a single line with 2 units or two lines with 67028-RT and 67028-LT-51. The injected medication (e.g. J0178) is billed on separate lines with the exact units administered and discarded.
What are the documentation rules for anti-VEGF drug wastage (Modifier JW vs JZ)?
CMS mandates Modifier JZ when zero drug is discarded from a single-dose vial, and Modifier JW on a separate claim line reporting the exact number of discarded units. The clinical record must explicitly document the total vial volume, administered dose, and discarded remainder.